$28.32−0.66 (−2.27%)
Market open · 15-min delayed · as of 12:09 PM ET
Structure Therapeutics Inc · Tenets
How GPCR measures up against value, income, timing, and long-hold tenets. Every criterion shows the live number and the pass rule. Always free.
The tenets below and the 0-100 Tenet Score on this report are two separate computations: each tenet runs its own criteria and its own pass rule, while the score is a percentile composite reported as one of four verdict words (Strong, Solid, Mixed or Weak).
0 / 17 qualify todayas of 2026-10-02 · computed nightly from our fundamentals DB; point-in-time auditable.
QUALIFIES
0
meet every gate today
BORDERLINE
1
within one input of the gate
FAILS
8
miss at least one gate
UNKNOWN
8
insufficient data to judge
passesfailsborderlineunknown
Value — six classic philosophies
Buffett Qualitydurable moat
— Insufficient inputs (2 of 5 known)FailsROE ≥ 15%(TTM through Jun 30, 2026)−20.2% · ≥ 15.0%
Unknown — no dataGross margin ≥ 40%— · ≥ 40.0%
Unknown — no dataNet margin ≥ 15%— · ≥ 15.0%
Unknown — no dataDebt/equity ≤ 0.5— · ≤ 0.50
FailsGrowing FCF (multi-yr)Free cash flow was negative in fiscal 2025.no · > 0
Verdict Unknown for this set.Verdict Unknown for this set. 2 of 5 checks below carry data.Buffett Quality under The screens ›
Piotroski F-Scorefinancial strength
✕ 2 / 9FailsReturn on assets positive(fiscal 2025)−8.9% · > 0
FailsOperating cash flow positive(fiscal 2025)−$222.2M · > 0
PassesReturn on assets improving(fiscal 2025)−13.6% → −8.9%
FailsEarnings backed by cash (CFO > net income)(fiscal 2025)−$222.2M vs −$141.2M
FailsLeverage falling (long-term debt / assets)(fiscal 2025)We hold no record of long-term debt as a share of assets for both years for this company, so this signal could not be measured. It still scores 0 under this module's conservative rule (a point is never awarded without evidence), and it is not counted as one of the signals we were able to measure.no
PassesCurrent ratio improving(fiscal 2025)24.74 → 24.81
FailsNo share dilution (≤ +2%)(fiscal 2025)+12.5%
FailsGross margin expanding(fiscal 2025)This company files on a financial-statement template with no gross-profit line (banks and insurers do not report one), so gross margin could not be measured for either year. It still scores 0 under this module's conservative rule (a point is never awarded without evidence), and it is not counted as one of the signals we were able to measure.no
FailsAsset turnover improving(fiscal 2025)0.00 → 0.00
Decided by the pass rule for Piotroski F-Score.The pass rule for Piotroski F-Score is what decides that verdict, and it is not restated here. These checks score 2 of 9. 2 of 9 carry no data.Piotroski F-Score under The screens ›
Munger Compoundershigh-ROIC quality
— UnknownUnknown — no dataROIC ≥ 15%— · ≥ 15.0%
Unknown — no dataNet debt/EBITDA ≤ 3×— · ≤ 3.0×
Unknown — no dataAltman Z ≥ 3 (safe zone)— · ≥ 3.00
Verdict Unknown for this set.Verdict Unknown for this set. None of the 3 checks below carry data.Munger Compounders under The screens ›
Magic FormulaROC + earnings yield (threshold check; full rank needs universe)
— Insufficient inputs (1 of 3 known)FailsEBIT > 0(TTM through Jun 30, 2026)−$257.8M · > 0
Unknown — no dataEarnings yield EBIT/EV ≥ 6%— · ≥ 6.0%
Unknown — no dataReturn on capital ≥ 25%— · ≥ 25.0%
Verdict Unknown for this set.Verdict Unknown for this set. 1 of 3 checks below carry data. The pass rule for Magic Formula is not published separately on the methodology page.About this screen ›
Graham Defensivemargin of safety
— Insufficient inputs (3 of 7 known)PassesSize: market cap ≥ $2B$6.3B · ≥ $2.0B
PassesCurrent ratio ≥ 2(quarter ending Jun 30, 2026)20.75 · ≥ 2.00
FailsPositive EPS 6y0y
Unknown — no dataPays a dividend— · > 0
Unknown — no dataEPS growth ≥ 3%/yr— · ≥ 3.0%
Unknown — no dataP/E ≤ 15— · ≤ 15.00
Unknown — no dataP/E × P/B ≤ 22.5— · ≤ 22.50
Verdict Unknown for this set.Verdict Unknown for this set. 3 of 7 checks below carry data.Graham Defensive under The screens ›
Lynch GARPgrowth at reasonable price (historical-CAGR basis)
— UnknownUnknown — no dataPEG < 1 (hist. growth)— · < 1.00
Unknown — no dataEPS growth 10–30%— · 10.0%–30.0%
Verdict Unknown for this set.Verdict Unknown for this set. None of the 2 checks below carry data.Lynch GARP under The screens ›
Income — dividend safety
Income & Dividend Safetycoverage over headline yield
— UnknownUnknown — no dataPays a dividend— · > 0
Unknown — no dataYield in a healthy band (not a yield trap)— · 1.0%–8.0%
Unknown — no dataCovered by free cash flow— · ≥ 1.20
Unknown — no dataEarnings payout not stretched— · ≤ 75.0%
Unknown — no dataBalance sheet can sustain the payout— · ≤ 4.0×
Verdict Unknown for this set.Verdict Unknown for this set. None of the 5 checks below carry data. The pass rule for Income & Dividend Safety is not published separately on the methodology page.
Dividend Growthraises you can count on
— UnknownUnknown — no dataPays a dividend— · > 0
Unknown — no dataAnnual dividend raised 10+ years running (Aristocrat ≥25, King ≥50)— · ≥ 10.00
Unknown — no dataNo dividend cut in the last 5 years—
Unknown — no data5-year dividend growth ≥ 5%/yr— · ≥ 5.0%
Unknown — no dataCovered by free cash flow— · ≥ 1.20
Unknown — no dataPayout not stretched— · ≤ 75.0%
Verdict Unknown for this set.Verdict Unknown for this set. None of the 6 checks below carry data.Dividend Growth under The screens ›
Long Hold — quality compounders
Quality Compounderhigh returns, reinvested, few new shares
— Insufficient inputs (2 of 5 known)FailsReturn on invested capital ≥ 15% in 4+ of the last 5 years0 of 4 on file
Not scored: see the reason belowRevenue compounding ≥ 8%/yr over 5 yearsFive-year revenue history is incomplete in our data, so the compounding rate can't be computed yet.— · ≥ 8.0%
FailsNot diluting: diluted share count flat-to-down (≤ +1%/yr)37.2% · ≤ 1.0%
Not scored: see the reason belowFree cash flow margin ≥ 12%Free-cash-flow margin isn't derivable yet from the statements we have on file.— · ≥ 12.0%
Not scored: see the reason belowEarnings backed by cash (operating cash flow ≥ net income)Cash-flow-to-earnings quality isn't available in our data for this period.— · ≥ 1.00
Reading: does not hold. Not a gate checkDisciplined buybacks: actively reducing the share count (bonus)reading, not a gate check37.2%
Verdict Unknown for this set.Verdict Unknown for this set. 2 of 5 checks below carry data. Lines marked as readings are published beside the checks and are not gate checks.Quality Compounder under The screens ›
Timing — dip & swing receipts
Drawdown Contexta dip, not a collapse
✕ FailsFailsOff its 52-week high by 8–35% (a dip, not a collapse)69.5% · 8.0%–35.0%
FailsDip within its own normal pullback band0.47
FailsNot past where its dips have historically recovered from2.97
FailsA dip in an uptrend (above a rising 200-day)53.70
FailsHigher-low structure still intactstructure broken · higher low
PassesClear of the earnings blackout (more than 5 days out)42.00 · > 5.00
Decided by the pass rule for Drawdown Context.The pass rule for Drawdown Context is what decides that verdict, and it is not published separately on the methodology page.
Reversal Evidencedaily close onlysigns the pullback is turning
✕ FailsUnknown — no dataA bullish MACD cross within 10 sessions— · ≤ 10.00
FailsReclaimed a rising 50-day EMA42.31
PassesPrinted a higher lowyes
FailsA volume thrust on the turn (≥ 1.2× normal)0.91 · ≥ 1.20
FailsReversal signals fired: 3 of 4 (MACD·MA·HL·Vol)1.00 · ≥ 3.00
Decided by the pass rule for Reversal Evidence.The pass rule for Reversal Evidence is what decides that verdict, and it is not published separately on the methodology page. 1 of 5 carry no data.
Not-a-Value-Trap Gatecheap for a good reason, not a broken one
✕ FailsUnknown — no dataIn the cheap half of its own 5-year valuation range—
FailsEarnings estimates not being cut−0.16
PassesReturns on capital not deteriorating−0.08
Decided by the pass rule for Not-a-Value-Trap Gate.The pass rule for Not-a-Value-Trap Gate is what decides that verdict, and it is not published separately on the methodology page. 1 of 3 carry no data.
Quality Floorpasses the quality/value gate on this dip
✕ FailsFailsOperating profit is positive(TTM through Jun 30, 2026)−$257.8M · > 0
FailsReturn on invested capital ≥ 10%(TTM through Jun 30, 2026)−19.0% · ≥ 10.0%
Not scored: see the reason belowA solvent balance sheet (Altman Z ≥ 1.8, net debt/EBITDA ≤ 4)Neither half of this two-part test is derivable from the statements we have on file, so it is left unscored.—
FailsQuality score ≥ 5031.90 · ≥ 50.00
Unknown — no dataRevenue growing over 5 years— · > 0
Decided by the pass rule for Quality Floor.The pass rule for Quality Floor is what decides that verdict, and it is not published separately on the methodology page. 2 of 5 carry no data.
Qualified Dipa pullback with receipts, not a falling knife
~ BorderlineA research signal from published criteria, not a recommendation.
FailsDrawdown context69.5% off its 52-week high
FailsReversal evidence1 of 4 signals fired
FailsTrap gate1 of 3 held · 1 no data
FailsQuality floor0 of 5 held · 2 no data
Invalidation level (structure break): below this the dip's structure has broken$46.03
Decided by the pass rule for Qualified Dip.The pass rule for Qualified Dip is what decides that verdict, and it is not restated here.Qualified Dip under The screens ›
Trend Alignmentprice in a confirmed uptrend
✕ FailsFailsTrading above its 50-day average45.17
FailsTrading above its 200-day average53.70
Fails50-day average above the 200-day (uptrend stack)45.17
Fails50-day average sloping up−0.11 · > 0
Decided by the pass rule for Trend Alignment.The pass rule for Trend Alignment is what decides that verdict, and it is not published separately on the methodology page.
Relative Strengthoutperforming, ranked vs the universe
✕ FailsFails3-month return in the top half of the universe0.03 · ≥ 0.50
Passes12-minus-1 momentum in the top half of the universe0.88 · ≥ 0.50
FailsRelative strength vs the S&P 500 improving−0.01 · > 0
FailsEarnings estimates being revised up−0.16
Decided by the pass rule for Relative Strength.The pass rule for Relative Strength is what decides that verdict, and it is not published separately on the methodology page.
Momentum Triggera trigger you can see
✕ FailsFailsMACD above its signal line−3.99
Not scored: see the reason belowBack above the 50-day on a fresh cross (≤10 sessions)This is a two-part reading (price back above the 50-day, and a bullish momentum cross inside 10 sessions) and a dated momentum cross is not on record for this name yet, so it is left unscored rather than counted either way.—
FailsHigher high and higher low (stair-stepping up)no higher high · higher low
FailsA volume thrust on the move (≥ 1.2× normal)0.91 · ≥ 1.20
Decided by the pass rule for Momentum Trigger.The pass rule for Momentum Trigger is what decides that verdict, and it is not published separately on the methodology page. 1 of 4 carry no data.
Volatility Regimecontext, not a signal
Context, not scoredAverage daily swing: high0.08
Volatility band width: expanded (wide range)0.86
Distance from its 52-week high: a deep pullback0.69
✓
Every verdict is auditableEach criterion shows the live number and the pass rule side by side — a receipt, not a rating. Several of these screens publish their rule in full under The screens; each row links to its own section where there is one.
!
Unknown ≠ failAn “— Unknown” verdict means the inputs were insufficient: context, not a signal, and never counted as a fail.
Computed from our fundamentals DB; historical-CAGR PEG basis for Lynch. Research, not investment advice. Tenet's rulesets are independently developed from publicly available sources, and Tenet is not affiliated with, sponsored by, endorsed by or otherwise associated with any referenced investor or trademark owner. Full notice. MAGIC FORMULA is a trademark of MagicFormulaInvesting.com LLC.